“…43 Social cognition (Table 3). Seventeen studies of low-quality according to the QUADAS-2 appraisal 17,19,29,32,33,37,40,[46][47][48][49][50]52,[54][55][56][57] used social cognition tests to differentiate bvFTD from healthy controls and other conditions, including AD, PSP, CBS, PPA, MDD, BDI, presymptomatic FTD genetic carriers and mixed neurological and/ or psychiatric cohorts. Social cognition tests were consistently reported as good to excellent at differentiating bvFTD from healthy controls, presymptomatic FTD genetic carriers, AD, and MDD.…”